These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 22045708)
41. Tumor angiogenesis and accessibility: role of vascular endothelial growth factor. Jain RK Semin Oncol; 2002 Dec; 29(6 Suppl 16):3-9. PubMed ID: 12516032 [TBL] [Abstract][Full Text] [Related]
42. The addition of AG-013736 to fractionated radiation improves tumor response without functionally normalizing the tumor vasculature. Fenton BM; Paoni SF Cancer Res; 2007 Oct; 67(20):9921-8. PubMed ID: 17942924 [TBL] [Abstract][Full Text] [Related]
45. Annexin A5-conjugated polymeric micelles for dual SPECT and optical detection of apoptosis. Zhang R; Lu W; Wen X; Huang M; Zhou M; Liang D; Li C J Nucl Med; 2011 Jun; 52(6):958-64. PubMed ID: 21571801 [TBL] [Abstract][Full Text] [Related]
47. Targeted systemic radiotherapy with scVEGF/177Lu leads to sustained disruption of the tumor vasculature and intratumoral apoptosis. Blankenberg FG; Levashova Z; Goris MG; Hamby CV; Backer MV; Backer JM J Nucl Med; 2011 Oct; 52(10):1630-7. PubMed ID: 21890879 [TBL] [Abstract][Full Text] [Related]
48. Apoptosis imaging probe predicts early chemotherapy response in preclinical models: A comparative study with 18F-FDG PET. Song S; Xiong C; Lu W; Ku G; Huang G; Li C J Nucl Med; 2013 Jan; 54(1):104-10. PubMed ID: 23283564 [TBL] [Abstract][Full Text] [Related]
49. Inhibition of carcinoma cell-derived VEGF reduces inflammatory characteristics in xenograft carcinoma. Salnikov AV; Heldin NE; Stuhr LB; Wiig H; Gerber H; Reed RK; Rubin K Int J Cancer; 2006 Dec; 119(12):2795-802. PubMed ID: 17019708 [TBL] [Abstract][Full Text] [Related]
50. Tumor stromal architecture can define the intrinsic tumor response to VEGF-targeted therapy. Smith NR; Baker D; Farren M; Pommier A; Swann R; Wang X; Mistry S; McDaid K; Kendrew J; Womack C; Wedge SR; Barry ST Clin Cancer Res; 2013 Dec; 19(24):6943-56. PubMed ID: 24030704 [TBL] [Abstract][Full Text] [Related]
51. Imaging of therapy-induced apoptosis using (99m)Tc-HYNIC-annexin V in thymoma tumor-bearing mice. Wong E; Kumar V; Howman-Giles RB; Vanderheyden JL Cancer Biother Radiopharm; 2008 Dec; 23(6):715-26. PubMed ID: 19111046 [TBL] [Abstract][Full Text] [Related]
52. Bevacizumab radiosensitizes non-small cell lung cancer xenografts by inhibiting DNA double-strand break repair in endothelial cells. Gao H; Xue J; Zhou L; Lan J; He J; Na F; Yang L; Deng L; Lu Y Cancer Lett; 2015 Aug; 365(1):79-88. PubMed ID: 25982206 [TBL] [Abstract][Full Text] [Related]
53. Tumor vessel biology in pediatric intracranial ependymoma. Wagemakers M; Sie M; Hoving EW; Molema G; de Bont ES; den Dunnen WF J Neurosurg Pediatr; 2010 Apr; 5(4):335-41. PubMed ID: 20367336 [TBL] [Abstract][Full Text] [Related]
54. Antitumor effect of FP3 on a patient-derived tumor tissue xenograft model of rectal carcinoma. Bi T; Bi T; Lan H; Hu X; Zhu M; Xu Z; Hu J; Teng L; Jin K Hepatogastroenterology; 2013; 60(128):1950-4. PubMed ID: 24719933 [TBL] [Abstract][Full Text] [Related]
55. 99mTc-annexin V imaging for in vivo detection of atherosclerotic lesions in porcine coronary arteries. Johnson LL; Schofield L; Donahay T; Narula N; Narula J J Nucl Med; 2005 Jul; 46(7):1186-93. PubMed ID: 16000288 [TBL] [Abstract][Full Text] [Related]
57. Targeting angiogenesis in cancer: clinical development of bevacizumab. Kerr DJ Nat Clin Pract Oncol; 2004 Nov; 1(1):39-43. PubMed ID: 16264798 [TBL] [Abstract][Full Text] [Related]
58. Tan H; Zhou J; Yang X; Abudupataer M; Li X; Hu Y; Xiao J; Shi H; Cheng D Sci Rep; 2017 Jun; 7(1):3504. PubMed ID: 28615707 [TBL] [Abstract][Full Text] [Related]
59. Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models. Chang YS; Adnane J; Trail PA; Levy J; Henderson A; Xue D; Bortolon E; Ichetovkin M; Chen C; McNabola A; Wilkie D; Carter CA; Taylor IC; Lynch M; Wilhelm S Cancer Chemother Pharmacol; 2007 Apr; 59(5):561-74. PubMed ID: 17160391 [TBL] [Abstract][Full Text] [Related]
60. Can 111In-RGD2 monitor response to therapy in head and neck tumor xenografts? Terry SY; Abiraj K; Lok J; Gerrits D; Franssen GM; Oyen WJ; Boerman OC J Nucl Med; 2014 Nov; 55(11):1849-55. PubMed ID: 25349221 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]